SO
SNNA

STRS Ohio’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

STRS Ohio’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,300
Closed -$80K – 2227
2018
Q1 		$80K Buy
4,300
+2,800
+187% +$48.9K ﹤0.01% 1662
2017
Q4 		$27K Hold
1,500
– – ﹤0.01% 1802
2017
Q3 		$33K Buy
+1,500
New +$32.9K ﹤0.01% 1839

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

STRS Ohio's SNNA Position: Q2 2018 in Review

STRS Ohio sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q2 2018, closing a stake of 4,300 shares — an estimated $80K sold.

STRS Ohio first reported a position in SNNA in Q3 2017 and held it in 3 quarters. The position peaked at $80K in Q1 2018. 53 funds tracked by Wall St. Rank hold SNNA as of Q2 2018.

  • STRS Ohio reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • STRS Ohio sold 4,300 Sienna Biopharmaceuticals, Inc. shares in Q2 2018, an estimated $80K.
  • STRS Ohio first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and held it in 3 quarters.
  • STRS Ohio's Sienna Biopharmaceuticals, Inc. position peaked at $80K in Q1 2018.
  • 53 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q2 2018.

Based on STRS Ohio's 13F filing for Q2 2018, filed 6 Aug 2018.